Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Total Revenue

Rigel Pharmaceuticals Total Revenue Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Total Revenue from 2010 to 2020. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Rigel Pharmaceuticals Total Revenue for the quarter ending June 06, 2020 was $16m a -30.19% decrease of -5m year over year
  • Rigel Pharmaceuticals Total Revenue for the last 12 months ending June 06, 2020 was $108m a 24.34% increase of 26m year over year
  • Rigel Pharmaceuticals Annual Total Revenue for 2019 was $59m a 24.93% increase of 15m from 2018
  • Rigel Pharmaceuticals Annual Total Revenue for 2018 was $45m a 89.93% increase of 40m from 2017
  • Rigel Pharmaceuticals Annual Total Revenue for 2017 was $4m a -354.57% decrease of -16m from 2016
Other Income Statement Metrics:
  • Rigel Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $3m a 1,013.58% increase of 27m year over year
  • Rigel Pharmaceuticals Net Income for the quarter ending December 12, 2018 was $3m a 855.42% increase of 28m year over year
View Chart On Koyfin

Quarterly RIGL Total Revenue Data

06/2020$16m
03/2020$56m
12/2019$15m
09/2019$21m
06/2019$10m
03/2019$13m
12/2018$38m
09/2018$5m
06/2018$2m
12/2017$0m

Annual RIGL Total Revenue Data

2019$59m
2018$45m
2017$4m
2016$20m
2015$29m
2014$8m
2013$7m
2012$2m
2011$5m
2010$125m